{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:28:32Z","timestamp":1760203712521},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[1999,10,1]]},"DOI":"10.1038\/sj.gt.3301004","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T16:50:10Z","timestamp":1032367810000},"page":"1728-1733","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene"],"prefix":"10.1038","volume":"6","author":[{"given":"P","family":"Colmenero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Liljestr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Jondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,10,6]]},"reference":[{"key":"BF3301004_CR1","first-page":"53","volume":"4","author":"N Fernandez","year":"1998","unstructured":"Fernandez N et al. Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects Cytokin Cell Molec Ther 1998 4: 53\u201365","journal-title":"Cytokin Cell Molec Ther"},{"key":"BF3301004_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nm0598supp-525","volume":"4","author":"DM Pardoll","year":"1998","unstructured":"Pardoll DM . Cancer vaccines Nature Med 1998 4: 525\u2013531","journal-title":"Nature Med"},{"key":"BF3301004_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"SA Rosenberg","year":"1998","unstructured":"Rosenberg SA et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma (see comments) Nature Med 1998 4: 321\u2013327","journal-title":"Nature Med"},{"key":"BF3301004_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm0398-328","volume":"4","author":"FO Nestle","year":"1998","unstructured":"Nestle FO et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells (see comments) Nature Med 1998 4: 328\u2013332","journal-title":"Nature Med"},{"key":"BF3301004_CR5","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1073\/pnas.95.3.1178","volume":"95","author":"OCK Staveley","year":"1998","unstructured":"Staveley OCK et al. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression Proc Natl Acad Sci USA 1998 95: 1178\u20131183","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301004_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","volume":"76","author":"RN Germain","year":"1994","unstructured":"Germain RN . MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation Cell 1994 76: 287\u2013299","journal-title":"Cell"},{"key":"BF3301004_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/0952-7915(94)90075-2","volume":"6","author":"S Ostrand-Rosenberg","year":"1994","unstructured":"Ostrand-Rosenberg S . Tumor immunotherapy: the tumor cell as an antigen-presenting cell Curr Opin Immunol 1994 6: 722\u2013727","journal-title":"Curr Opin Immunol"},{"key":"BF3301004_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/meth.1997.0463","volume":"12","author":"EM Jaffee","year":"1997","unstructured":"Jaffee EM, Pardoll DM . Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines Methods 1997 12: 143\u2013153","journal-title":"Methods"},{"key":"BF3301004_CR9","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1089\/hum.1996.7.16-1955","volume":"7","author":"F Arienti","year":"1996","unstructured":"Arienti F et al. Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells Hum Gene Ther 1996 7: 1955\u20131963","journal-title":"Hum Gene Ther"},{"key":"BF3301004_CR10","first-page":"1537","volume":"57","author":"JW Simons","year":"1997","unstructured":"Simons JW et al. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte\u2013macrophage colony-stimulating factor gene transfer Cancer Res 1997 57: 1537\u20131546","journal-title":"Cancer Res"},{"key":"BF3301004_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","volume":"9","author":"BJ Van den Eynde","year":"1997","unstructured":"Van den Eynde BJ, van der Bruggen P . T cell defined tumor antigens Curr Opin Immunol 1997 9: 684\u2013693","journal-title":"Curr Opin Immunol"},{"key":"BF3301004_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1084\/jem.173.6.1373","volume":"173","author":"B Van den Eynde","year":"1991","unstructured":"Van den Eynde B et al. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA\/2 mice J Exp Med 1991 173: 1373\u20131384","journal-title":"J Exp Med"},{"key":"BF3301004_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0248-4900(94)90001-9","volume":"81","author":"A Amar-Costesec","year":"1994","unstructured":"Amar-Costesec A et al. Identification and characterization of the tumor-specific P1A gene product Biol Cell 1994 81: 195\u2013203","journal-title":"Biol Cell"},{"key":"BF3301004_CR14","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/eji.1830220916","volume":"22","author":"B Lethe","year":"1992","unstructured":"Lethe B et al. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide Eur J Immunol 1992 22: 2283\u20132288","journal-title":"Eur J Immunol"},{"key":"BF3301004_CR15","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P van der Bruggen","year":"1991","unstructured":"van der Bruggen P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 1991 254: 1643\u20131647","journal-title":"Science"},{"key":"BF3301004_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-065X.1995.tb00084.x","volume":"145","author":"A Van Pel","year":"1995","unstructured":"Van Pel A et al. Genes coding for tumor antigens recognized by cytolytic T lymphocytes Immunol Rev 1995 145: 229\u2013250","journal-title":"Immunol Rev"},{"key":"BF3301004_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.0.CO;2-A","volume":"70","author":"C Uyttenhove","year":"1997","unstructured":"Uyttenhove C et al. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen Int J Cancer 1997 70: 349\u2013356","journal-title":"Int J Cancer"},{"key":"BF3301004_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<303::AID-IJC24>3.0.CO;2-A","volume":"67","author":"G Warnier","year":"1996","unstructured":"Warnier G et al. Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A Int J Cancer 1996 67: 303\u2013310","journal-title":"Int J Cancer"},{"key":"BF3301004_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1089\/hum.1997.8.12-1451","volume":"8","author":"A Rosato","year":"1997","unstructured":"Rosato A et al. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A Hum Gene Ther 1997 8: 1451\u20131458","journal-title":"Hum Gene Ther"},{"key":"BF3301004_CR20","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/jvi.70.6.3781-3787.1996","volume":"70","author":"NL Davis","year":"1996","unstructured":"Davis NL, Brown KW, Johnston RE . A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge J Virol 1996 70: 3781\u20133787","journal-title":"J Virol"},{"key":"BF3301004_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1006\/viro.1995.1516","volume":"212","author":"KV Pugachev","year":"1995","unstructured":"Pugachev KV, Mason PW, Shope RE, Frey TK . Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection Virology 1995 212: 587\u2013594","journal-title":"Virology"},{"key":"BF3301004_CR22","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1073\/pnas.92.7.3009","volume":"92","author":"X Zhou","year":"1995","unstructured":"Zhou X et al. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus Proc Natl Acad Sci USA 1995 92: 3009\u20133013","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301004_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nbt0698-562","volume":"16","author":"P Berglund","year":"1998","unstructured":"Berglund P et al. Enhancing immune responses using suicidal DNA vaccines (see comments) Nature Biotechnol 1998 16: 562\u2013565","journal-title":"Nature Biotechnol"},{"key":"BF3301004_CR24","first-page":"508","volume":"17","author":"P Berglund","year":"1998","unstructured":"Berglund P, Fleeton MN, Smerdou C, Liljestr\u00f6m P . Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice Vaccine 1998 17: 508\u2013518","journal-title":"Vaccine"},{"key":"BF3301004_CR25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nbt1291-1356","volume":"9","author":"P Liljestr\u00f6m","year":"1991","unstructured":"Liljestr\u00f6m P, Garoff H . A new generation of animal cell expression vectors based on the Semliki Forest virus replicon Nature Biotechnol 1991 9: 1356\u20131361","journal-title":"Nature Biotechnol"},{"key":"BF3301004_CR26","first-page":"916","volume":"11","author":"P Berglund","year":"1993","unstructured":"Berglund P et al. Semliki Forest virus expression system: production of conditionally infectious recombinant particles Bio\/Technology 1993 11: 916\u2013920","journal-title":"Bio\/Technology"},{"key":"BF3301004_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1089\/aid.1997.13.1487","volume":"13","author":"P Berglund","year":"1997","unstructured":"Berglund P et al. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus AIDS Res Hum Retrovir 1997 13: 1487\u20131495","journal-title":"AIDS Res Hum Retrovir"},{"key":"BF3301004_CR28","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/jvi.70.3.1953-1960.1996","volume":"70","author":"SP Mossman","year":"1996","unstructured":"Mossman SP et al. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine J Virol 1996 70: 1953\u20131960","journal-title":"J Virol"},{"key":"BF3301004_CR29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1099\/0022-1317-80-5-1189","volume":"80","author":"MN Fleeton","year":"1999","unstructured":"Fleeton MN et al. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge J Gen Virol 1999 80: 1189\u20131198","journal-title":"J Gen Virol"},{"key":"BF3301004_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/eji.1830250306","volume":"25","author":"VG Brichard","year":"1995","unstructured":"Brichard VG et al. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815 Eur J Immunol 1995 25: 664\u2013671","journal-title":"Eur J Immunol"},{"key":"BF3301004_CR31","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/eji.1830251013","volume":"25","author":"U Grohmann","year":"1995","unstructured":"Grohmann U et al. CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tumor helper peptides in priming for skin test reactivity to a P815AB-relatedpeptide Eur J Immunol 1995 25: 2797\u20132802","journal-title":"Eur J Immunol"},{"key":"BF3301004_CR32","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.4049\/jimmunol.160.11.5522","volume":"160","author":"H Bour","year":"1998","unstructured":"Bour H et al. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization J Immunol 1998 160: 5522\u20135529","journal-title":"J Immunol"},{"key":"BF3301004_CR33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4049\/jimmunol.156.3.1095","volume":"156","author":"F Fallarino","year":"1996","unstructured":"Fallarino F, Uyttenhove C, Boon T, Gajewski TF . Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo J Immunol 1996 156: 1095\u20131100","journal-title":"J Immunol"},{"key":"BF3301004_CR34","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1084\/jem.152.5.1175","volume":"152","author":"C Uyttenhove","year":"1980","unstructured":"Uyttenhove C, Van Snick J, Boon T . Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice J Exp Med 1980 152: 1175\u20131183","journal-title":"J Exp Med"},{"key":"BF3301004_CR35","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1084\/jem.157.3.1040","volume":"157","author":"C Uyttenhove","year":"1983","unstructured":"Uyttenhove C, Maryanski J, Boon T . Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression J Exp Med 1983 157: 1040\u20131052","journal-title":"J Exp Med"},{"key":"BF3301004_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0065-2776(08)60309-0","volume":"18","author":"HF Pross","year":"1974","unstructured":"Pross HF, Eidinger D . Antigenic competition: a review of nonspecific antigen-induced suppression Adv Immunol 1974 18: 133\u2013168","journal-title":"Adv Immunol"},{"key":"BF3301004_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/eji.1830260323","volume":"26","author":"C Heufler","year":"1996","unstructured":"Heufler C et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells Eur J Immunol 1996 26: 659\u2013668","journal-title":"Eur J Immunol"},{"key":"BF3301004_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevImmunol.v18.i1-2.100","volume":"18","author":"U Grohmann","year":"1998","unstructured":"Grohmann U et al. Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor\/self peptide Crit Rev Immunol 1998 18: 87\u201398","journal-title":"Crit Rev Immunol"},{"key":"BF3301004_CR39","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1099\/0022-1317-78-7-1559","volume":"78","author":"GM Glasgow","year":"1997","unstructured":"Glasgow GM, McGee MM, Sheahan BJ, Atkins GJ . Death mechanisms in cultured cells infected by Semliki Forest virus J Gen Virol 1997 78: 1559\u20131563","journal-title":"J Gen Virol"},{"key":"BF3301004_CR40","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0167-5699(98)01301-2","volume":"19","author":"FR Carbone","year":"1998","unstructured":"Carbone FR et al. Cross-presentation: a general mechanism for CTL immunity and tolerance Immunol Today 1998 19: 368\u2013373","journal-title":"Immunol Today"},{"key":"BF3301004_CR41","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/intimm\/9.12.1897","volume":"9","author":"JS Boyle","year":"1997","unstructured":"Boyle JS, Koniaras C, Lew AM . Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization Int Immunol 1997 9: 1897\u20131906","journal-title":"Int Immunol"},{"key":"BF3301004_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/dna.1997.16.185","volume":"16","author":"G Inchauspe","year":"1997","unstructured":"Inchauspe G et al. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization DNA Cell Biol 1997 16: 185\u2013195","journal-title":"DNA Cell Biol"},{"key":"BF3301004_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0161-5890(97)00078-3","volume":"34","author":"M Kjerrulf","year":"1997","unstructured":"Kjerrulf M, Lowenadler B, Svanholm C, Lycke N . Tandem repeats of T helper epitopes enhance immunogenicity of fusion proteins by promoting processing and presentation Molec Immunol 1997 34: 599\u2013608","journal-title":"Molec Immunol"},{"key":"BF3301004_CR44","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/0161-5890(92)90054-2","volume":"29","author":"B Lowenadler","year":"1992","unstructured":"Lowenadler B et al. T and B cell responses to chimeric proteins containing heterologous T helper epitopes inserted at different positions Molec Immunol 1992 29: 1185\u20131190","journal-title":"Molec Immunol"},{"key":"BF3301004_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1084\/jem.182.1.261","volume":"182","author":"P Aichele","year":"1995","unstructured":"Aichele P et al. T cell priming versus T cell tolerance induced by synthetic peptides J Exp Med 1995 182: 261\u2013266","journal-title":"J Exp Med"},{"key":"BF3301004_CR46","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.1073\/pnas.93.15.7855","volume":"93","author":"RE Toes","year":"1996","unstructured":"Toes RE et al. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction Proc Natl Acad Sci USA 1996 93: 7855\u20137860","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301004_CR47","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0952-7915(96)80082-3","volume":"8","author":"NP Restifo","year":"1996","unstructured":"Restifo NP . The new vaccines: building viruses that elicit antitumor immunity Curr Opin Immunol 1996 8: 658\u2013663","journal-title":"Curr Opin Immunol"},{"key":"BF3301004_CR48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/319543a0","volume":"319","author":"L Jones","year":"1986","unstructured":"Jones L, Ristow S, Yilma T, Moss B . Accidental human vaccination with vaccinia virus expressing nucleoprotein gene (letter) Nature 1986 319: 543","journal-title":"Nature"},{"key":"BF3301004_CR49","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/jvi.62.5.1530-1534.1988","volume":"62","author":"JF Rooney","year":"1988","unstructured":"Rooney JF et al. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination J Virol 1988 62: 1530\u20131534","journal-title":"J Virol"},{"key":"BF3301004_CR50","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/0264-410X(93)90079-D","volume":"11","author":"TM Kundig","year":"1993","unstructured":"Kundig TM, Kalberer CP, Hengartner H, Zinkernagel RM . Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination Vaccine 1993 11: 1154\u20131158","journal-title":"Vaccine"},{"key":"BF3301004_CR51","first-page":"137","volume":"3","author":"Y Yang","year":"1996","unstructured":"Yang Y et al. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo Gene Therapy 1996 3: 137\u2013144","journal-title":"Gene Therapy"},{"key":"BF3301004_CR52","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nbt1194-1127","volume":"12","author":"EM Sjoberg","year":"1994","unstructured":"Sjoberg EM, Suomalainen M, Garoff H . A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene Bio\/Technology 1994 12: 1127\u20131131","journal-title":"Bio\/Technology"},{"key":"BF3301004_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1083\/jcb.116.2.349","volume":"116","author":"A Salminen","year":"1992","unstructured":"Salminen A et al. Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry J Cell Biol 1992 116: 349\u2013357","journal-title":"J Cell Biol"},{"key":"BF3301004_CR54","first-page":"16.20.1","volume-title":"Expression of proteins using Semliki Forest virus vectors.","author":"P Liljestr\u00f6m","year":"1994","unstructured":"Liljestr\u00f6m P, Garoff H . Expression of proteins using Semliki Forest virus vectors. In: Ausubel FM et al (eds). Current Protocols in Molecular Biology Greene Publishing Associates and Wiley Interscience: New York 1994 16.20.1\u201316.20.16"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301004","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T01:23:24Z","timestamp":1704590604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10,1]]}},"alternative-id":["BF3301004"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301004","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10,1]]},"assertion":[{"value":"8 March 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}